Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway

BACKGROUND: Previous studies have shown that Ampelopsin has an inhibitory effect on human tumors. However, the effect of Ampelopsin on renal cell carcinoma (RCC) is rarely reported. Therefore, this study aims to explain the role of Ampelopsin in RCC. METHODS: Different concentrations of Ampelopsin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhonghe, Jiang, Yan, Liu, Zhongguo, Li, Qingyan, Gao, Tiantian, Zhang, Shengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601800/
https://www.ncbi.nlm.nih.gov/pubmed/34804180
http://dx.doi.org/10.1155/2021/4650566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601800/
https://www.ncbi.nlm.nih.gov/pubmed/34804180
http://dx.doi.org/10.1155/2021/4650566

Ejemplares similares